http://sttm.technologypublisher.comBe the first to know about the latest inventions and technologies available from South Texas Technology Managementen-USThu, 29 Jul 2010 13:18:26 GMTFri, 18 Jun 2010 07:43:22 GMThttp://blogs.law.harvard.edu/tech/rssrodriguezr21@uthscsa.eduCopyright 2010, http://sttm.technologypublisher.com/technology/5328 United States Patent 7,125,841 Sheehan October 24, 2006 Mutant human factor IX with an increased resistance to inhibition by heparin Abstract The present invention is related to a novel composition of matter and methods of using the same. More particularly, the invention describes mutant human factor IX which has an increased resistance to inhibition by heparin. Methods of making and using this composition for the therapeutic intervention of hemophilia are disclosed. Fri, 18 Jun 2010 07:43:22 GMTrodriguezr21@uthscsa.eduhttp://sttm.technologypublisher.com/technology/5328http://sttm.technologypublisher.com/technology/5327Fri, 18 Jun 2010 07:43:09 GMTrodriguezr21@uthscsa.eduhttp://sttm.technologypublisher.com/technology/5327http://sttm.technologypublisher.com/technology/5326Fri, 18 Jun 2010 07:43:07 GMTrodriguezr21@uthscsa.eduhttp://sttm.technologypublisher.com/technology/5326http://sttm.technologypublisher.com/technology/5325Fri, 18 Jun 2010 07:43:06 GMTrodriguezr21@uthscsa.eduhttp://sttm.technologypublisher.com/technology/5325http://sttm.technologypublisher.com/technology/4990Tue, 27 Apr 2010 06:36:19 GMTrodriguezr21@uthscsa.eduhttp://sttm.technologypublisher.com/technology/4990http://sttm.technologypublisher.com/technology/4483Wed, 27 Jan 2010 12:16:57 GMTrodriguezr21@uthscsa.eduhttp://sttm.technologypublisher.com/technology/4483http://sttm.technologypublisher.com/technology/1519Wed, 04 Mar 2009 11:40:42 GMTrodriguezr21@uthscsa.eduhttp://sttm.technologypublisher.com/technology/1519http://sttm.technologypublisher.com/technology/1518Novel Vaccine Candidate: Protective Antigen Against Pneumococcal Infection Streptococcus pneumoniae is the leasing cause of community-acquired pneumonia, sepsis, and meningitis. Pneumococcal infection can lead to invasive pneumococcal disease (IPD), which is responsible for over a million deaths annually - more than all other vaccine-preventable diseases combined. Currently two vaccines protect against the most virulent serotypes of this pathogen. However, they are either surface sugar-based, and cannot illicit a strong immune response in populations such as children and the elderly, o...Wed, 04 Mar 2009 11:40:25 GMTrodriguezr21@uthscsa.eduhttp://sttm.technologypublisher.com/technology/1518http://sttm.technologypublisher.com/technology/1517A Method for Screening, Identifying, and Detecting Molecular Targets and Compounds for the Treatment of Conformational/Amyloidogenic/Degererative Diseases (CADDs) Evidence is accumulating that defective protein folding is one of the causes of various diseases including amyloidosis, cystic fibrosis and neurogenerative disorders such as prion disease, Alzheimer’s disease and Parkinson’s disease. These diseases have been referred as “conformational diseases” as endogenous proteins undergo a change in shape that leads to self-association and tissue deposition. For the most of these disease...Wed, 04 Mar 2009 11:40:08 GMTrodriguezr21@uthscsa.eduhttp://sttm.technologypublisher.com/technology/1517http://sttm.technologypublisher.com/technology/1513Wed, 04 Mar 2009 11:38:11 GMTrodriguezr21@uthscsa.eduhttp://sttm.technologypublisher.com/technology/1513http://sttm.technologypublisher.com/technology/1509Wed, 04 Mar 2009 11:30:41 GMTrodriguezr21@uthscsa.eduhttp://sttm.technologypublisher.com/technology/1509